OBGYN and Women's Health

Findings seen among postmenopausal women; association stronger in those postmenopausal for >10 years

Screening recommended every three years with cervical cytology for women aged 21 to 29 years, every five years with hrHPV screening at age 30 to 65 years

Authors say further reductions will require new discoveries, adoption of emerging interventions

For women who give birth, risk for incident systemic autoimmune rheumatic disease higher with infertility without fertility treatment

In 2022, 52.4 percent of rural hospitals and 35.7 percent of urban hospitals did not offer obstetric care

Five-year AUC with addition of previous mammogram images improves current visit mammogram AUC

Increased odds ratio seen for asthma onset with high exposure to butylparaben; risk associated with 4-nonylphenol varies by gender

No change seen in percentage of people who were uninsured from 2023 to first half of 2024; lower percentage had public coverage

Findings seen in pregnant or postpartum women who receive unusual or nonreportable clinical cell-fee DNA-sequencing results

Risk for ischemic heart disease elevated for initiators of tibolone or oral estrogen-progestin therapy